Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Sept. 15, 2014—This symposium in San Francisco, Oct. 17-18, will examine a a big data approach to biomarker discovery and clinical assay diagnostic assay development in oncology that Munich-based Definiens is calling tissue phenomics. Speakers include Definiens co-founder and Nobel Laureate Gerd Binnig, PhD. Learn more.
Aug. 8, 2014—In this white paper, SeraCare Life Sciences notes that “every laboratory must ask what are the appropriate [quality control] goals and what are the most cost-effective ways to achieve these goals.” The paper reviews how often to run controls, how many replicates to run, and covers useful ways to plot assay QC in real time. Read.
Aug. 8, 2014—Randy German, MT(ASCP), blood bank and laboratory quality manager at Hoag Memorial Hospital, will share best practices for nonconforming event and blood product deviation reporting and investigation in a 50-minute webinar hosted by Nouvation, maker of occurrence-tracking software. German will review regulatory requirements, discuss what should be reported, and explain effective root-cause analysis in a blame-free culture. To register, fill out this contact form and note your interest in the Sept. 24, 2014, webinar in the question field
Aug. 6, 2014—A two-day online conference Aug. 20-21 will cover a wide range of topic in genetics and genomics, such as RNAi, next-generation sequencing, genotyping, and molecular diagnostics. The meeting—sponsored by Thermo Fisher Scientific, Beckman Coulter, Roche, and other firms—will feature interactive, live streaming video sessions and a virtual exhibit floor. Faculty includes experts from MD Anderson Cancer Center, Dartmouth, and Stanford. Free CME, CE, and CEU credits are available. Register.
July 10, 2014—Instrumentation Laboratory is presenting two, hour-long educational sessions at the AACC’s Annual Meeting and Clinical Lab Expo. The first will feature Ted E. Warkentin, MD, and Pau Bruguera, PhD, on clinical and laboratory aspects of heparin-induced thrombocytopenia diagnostics (register). In the other workshop, Sharon Ehrmeyer, PhD, MT(ASCP), will talk about how to develop and implement individualized quality-control plans in POC testing (register).
June 2014—The Food and Drug Administration on April 24 approved use of the Roche Cobas HPV test as a primary standalone screen for cervical cancer in women 25 and older. CAP TODAY writer William Check, PhD, asked questions of Thomas S. Lorey, MD, medical director, TPMG Regional Reference Laboratory, Kaiser Permanente Northern California. Their questions and answers follow. For a discussion of the ATHENA data on which the FDA based its decision, see Dr. Check’s June story “Data spark new directions in cervical cancer.”
May 12, 2014—Sylvia L. Asa, MD, PhD, reviews her role in forming a pathology “dream team” at Toronto’s University Health Network to ensure the right pathologist sees the right specimen at the right time. Flexible staffing models, hospital partnerships, and technology adoption are key to innovating in diagnostics, she says. Watch the video.
May 7, 2014—CAP members should now complete the 2014 CAP Practice Characteristics Survey (PCS), if you haven’t done so already. Results from the survey will help the College set advocacy priorities and outline regional market pressures and environmental changes impacting the individual pathologist. After completing the survey, participants will be entered in a weekly prize drawing.
An expert on the diagnostic evaluation and management of hemorrhagic and thromboembolic disorders will explain one way to optimize efficiency and outcomes with regard to laboratory monitoring of heparin therapies. The April 30 event is free. Register.
An Applied Spectral Imaging April 8 webinar explains the company’s product, Tissue Match, in which a pathologist uses a brightfield H&E or IHC review to mark the exact region of interest for FISH scanning. The FISH technician then knows the exact area to analyze. Read more on how to register.
